MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Milestone Pharmaceuticals Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.70−0.01 (-1.02%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Milestone Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Milestone Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $87.16M | $166.30M |
| Enterprise Value | -$83.44M | $88.19M |
| PB Ratio | 4.78 | 2.03 |
| P/TBV Ratio | 4.78 | 2.29 |
Income (trailing twelve months)
| Measure | Milestone Pharmaceuticals | Industry median |
|---|---|---|
| Operating Income | -$78.38M | -$21.40M |
| Net Income | -$84.01M | -$22.46M |
| EBITDA | -$78.21M | -$16.91M |
Returns
| Measure | Milestone Pharmaceuticals | Industry median |
|---|---|---|
| Return on Equity (ROE) | -35522.6% | -53.2% |
| Return on Assets (ROA) | -73.4% | -40.9% |
| Return on Capital Employed (ROCE) | -49.2% | -38.1% |
Balance sheet
| Measure | Milestone Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $170.60M | $61.43M |
| Net Cash (Debt) | $170.60M | $15.35M |
| Net Cash Per Share | $1.37 | $0.66 |
| Equity (Book Value) | $18.22M | $49.09M |
| Book Value Per Share | $0.15 | $1.37 |
| Tangible Book Value | $18.22M | $23.52M |
| Working Capital | $158.14M | $76.81M |
Financial position
| Measure | Milestone Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 8.13 | 3.34 |
| Quick Ratio | 7.81 | 2.44 |
| Interest Coverage | -7.25 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Milestone Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$61.29M | -$12.35M |
| Capital Expenditures | -$356.00K | -$1.08M |
| Free Cash Flow | -$61.65M | -$20.22M |
| FCF Per Share | -$0.50 | -$0.42 |
Efficiency
| Measure | Milestone Pharmaceuticals | Industry median |
|---|---|---|
| Profits Per Employee | -$2.21M | -$703.34K |
| Employee Count | 38 | 74 |
Dividends and yields
| Measure | Milestone Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -96.4% | -23.3% |
| FCF Yield | -70.7% | -8.72% |
Shares
| Measure | Milestone Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 124,498,000 | 58,127,000 |
| Shares Change (QoQ) | 5.69% | 0.54% |
| Float | 123,348,000 | 49,136,700 |
| Shares Held by Insiders | 0.92% | 11.6% |
| Shares Held by Institutions | 40.8% | 59.4% |
Scores
| Measure | Milestone Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | -3.80 | -0.22 |
Calculated by StockData from Milestone Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.